SEC Form 4 · accession 0001144204-15-056849
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charlotte C. Arnold
Officer — Vice President and CFO
Period of report
Sep 25, 2015
Accepted (ET)
Sep 28, 2015 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 25, 2015 | M | 18,166 | $6.36 | A | 49,204 | D | |
| Common Stock | Sep 25, 2015 | M | 894 | $33.00 | A | 50,098 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $6.36 | Sep 25, 2015 | M | 18,166 | D | Jul 12, 2014 | Jul 11, 2023 | Common Stock | 18,166 | 22,167 | D |
| Option to Purchase Common Stock | $33.00 | Sep 25, 2015 | M | 894 | D | Apr 1, 2015 | Mar 31, 2024 | Common Stock | 894 | 9,000 | D |